The association of CD81 polymorphisms with alloimmunization in sickle cell disease

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Tatari Calderone, Zohreh ^a,b   Tamouza, Ryad ^c   Le Bouder, Gama P ^a   Dewan, Ramita ^a   Luban, Naomi L C ^a,b   Lasserre, Jacqueline ^d   Maury, Jacqueline ^d   Lionnet, François ^d   Krishnamoorthy, Rajagopal ^e   Girot, Robert ^d   Vukmanovic, Stanislav ^a,b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c SAINT LOUIS HOSPITAL   (France)

^d HÔPITAL TENON   (France)

^e HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD81 ANTIGEN; ALLOANTIBODY; CD81 PROTEIN, HUMAN; CHRNA10 PROTEIN, HUMAN; NICOTINIC RECEPTOR; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOG PROTEIN, HUMAN;

ADULT; AGED; ALLOIMMUNIZATION; ARTICLE; CLINICAL ARTICLE; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MALE; PRIORITY JOURNAL; SICKLE CELL ANEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSFUSION; B LYMPHOCYTE; BIOSYNTHESIS; ERYTHROCYTE TRANSFUSION; GENE EXPRESSION; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; SIGNAL TRANSDUCTION;

ADULT; AGED; ANEMIA, SICKLE CELL; ANTIGENS, CD81; B-LYMPHOCYTES; BIOLOGICAL MARKERS; ERYTHROCYTE TRANSFUSION; FEMALE; GENE EXPRESSION; HUMANS; ISOANTIBODIES; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, NICOTINIC; RETROSPECTIVE STUDIES; RHO GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 84878637325     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/937846     Document Type: Article

References (75)

1. Smith-Whitley K., Herman J. H., Manno C. S., Alloimmunization in patients with sickle cell disease. Pediatric Transfusion Therapy 2002 AABB Press 249 282
2. Charache S., Bleecker E. R., Bross D. S., Effects of blood transfusion on exercise capacity in patients with sickle-cell anemia. American Journal of Medicine 1983 74 5 757 764 2-s2.0-0020631382 (Pubitemid 13080118)
3. Rosse W. F., Gallagher D., Kinney T. R., Castro O., Dosik H., Moohr J., Wang W., Levy P. S., Transfusion and alloimmunization in sickle cell disease. Blood 1990 76 7 1431 1437 2-s2.0-0025155742 (Pubitemid 20342762)
4. Seeler R. A., Intensive transfusion therapy for priapism in boys with sickle cell anemia. Journal of Urology 1973 110 3 360 361 2-s2.0-0015694486
5. Lusher J. M., Haghighat H., Khalifa A. S., A prophylactic transfusion program for children with sickle cell anemia complicated by CNS infarction. American Journal of Hematology 1976 1 2 265 273 2-s2.0-0017196848
6. Milner P. F., Chronic transfusion regimens in sickle cell disease. Progress in Clinical and Biological Research 1982 98 97 107 2-s2.0-0020349286
7. Piomelli S., Chronic transfusions in patients with sickle cell disease. Indications and problems. American Journal of Pediatric Hematology/Oncology 1985 7 1 51 55 2-s2.0-0021822097 (Pubitemid 15002509)
8. Petz L. D., Calhoun L., Shulman I. A., Johnson C., Herron R. M., The sickle cell hemolytic transfusion reaction syndrome. Transfusion 1997 37 4 382 392 2-s2.0-0030950506 (Pubitemid 27193551)
9. Ballas S. K., Lieff S., Benjamin L. J., Dampier C. D., Heeney M. M., Hoppe C., Johnson C. S., Rogers Z. R., Smith-Whitley K., Wang W. C., Telen M. J., Definitions of the phenotypic manifestations of sickle cell disease. American Journal of Hematology 2010 85 1 6 13 2-s2.0-74049123836 10.1002/ajh.21550
10. Yazdanbakhsh K., Ware R. E., Noizat-Pirenne F., Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood 2012 120 528 537
11. McPherson M. E., Anderson A. R., Castillejo M. I., Hillyer C. D., Bray R. A., Gebel H. M., Josephson C. D., HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease. Pediatric Blood and Cancer 2010 54 4 552 558 2-s2.0-77649128081 10.1002/pbc.22327
12. Orlina A. R., Unger P. J., Koshy M., Post-transfusion alloimmunization in patients with sickle cell disease. American Journal of Hematology 1978 5 2 101 106 2-s2.0-0018066896 (Pubitemid 9113345)
13. Luban N. L. C., Variability in rates of alloimmunization in different groups of children with sickle cell disease: effect of ethnic background. American Journal of Pediatric Hematology/Oncology 1989 11 3 314 319 2-s2.0-0024378049 (Pubitemid 19213452)
14. Vichinsky E. P., Earles A., Johnson R. A., Hoag M. S., Williams A., Lubin B., Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. The New England Journal of Medicine 1990 322 23 1617 1621 2-s2.0-0025372673 (Pubitemid 20171584)
15. Aygun B., Padmanabhan S., Paley C., Chandrasekaran V., Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 2002 42 1 37 43 2-s2.0-0036360040
16. Heddle N. M., Soutar R. L., O'Hoski P. L., Singer J., McBride J. A., Ali M. A. M., Kelton J. G., A prospective study to determine the frequency and clinical significance of alloimmunization post-transfusion. British Journal of Haematology 1995 91 4 1000 1005 2-s2.0-0028869143
17. Ness P. M., Shirey R. S., Thoman S. K., Buck S. A., The differentiation of delayed serologic and delayed hemolytic transfusion reactions: incidence, long-term serologic findings, and clinical significance. Transfusion 1990 30 8 688 693 2-s2.0-0025009074 (Pubitemid 20361782)
18. Pinkerton P. H., Coovadia A. S., Goldstein J., Frequency of delayed hemolytic transfusion reactions following antibody screening and immediate-spin crossmatching. Transfusion 1992 32 9 814 817 2-s2.0-0026735463 (Pubitemid 23001624)
19. Vamvakas E. C., Pineda A. A., Reisner R., Santrach P. J., Moore S. B., The differentiation of delayed hemolytic and delayed serologic transfusion reactions: incidence and predictors of hemolysis. Transfusion 1995 35 1 26 32 2-s2.0-0028888689
20. Storry J. R., Human Blood Groups: inheritance and importance in transfusion medicine. Journal of Infusion Nursing 2003 26 6 367 372 2-s2.0-0345714986 10.1097/00129804-200311000-00006 (Pubitemid 37443216)
21. Bashawri L. A. M., Red cell alloimmunization in sickle-cell anaemia patients. Eastern Mediterranean Health Journal 2007 13 5 1181 1189 2-s2.0-37849034859
22. Aly R., El-Sharnoby M. R., Hagag A. A., Frequency of red cell alloimmunization in patients with sickle cell anemia in an Egyptian referral hospital. Transfusion and Apheresis Science 2012 47 253 257
23. Ben Amor I., Louati N., Khemekhem H., Red blood cell immunization in haemoglobinopathie: about 84 cases. Transfusion Clinique et Biologique 2012 19 6 345 352 10.1016/j.tracli.2012.06.006
24. Natukunda B., Schonewille H., Ndugwa C., Brand A., Red blood cell alloimmunization in sickle cell disease patients in Uganda. Transfusion 2010 50 1 20 25 2-s2.0-73649108273 10.1111/j.1537-2995.2009.02435.x
25. Olujohungbe A., Hambleton I., Stephens L., Serjeant B., Serjeant G., Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom. British Journal of Haematology 2001 113 3 661 665 2-s2.0-0034983388 10.1046/j.1365-2141.2001.02819.x (Pubitemid 32524388)
26. Kwiatkowski D. P., How malaria has affected the human genome and what human genetics can teach us about malaria. American Journal of Human Genetics 2005 77 2 171 192 2-s2.0-22544441601 10.1086/432519 (Pubitemid 41022702)
27. Allison A. C., Protection afforded by sickle-cell trait against subtertian malareal infection. British Medical Journal 1954 1 4857 290 294 2-s2.0-77049164783
28. Tatari-Calderone Z., Minniti C. P., Kratovil T., Stojakovic M., Vollmer A., Barjaktarevic I., Zhang E., Hoang A., Luban N. L. C., Vukmanovic S., rs660 polymorphism in Ro52 (SSA1; TRIM 21) is a marker for age-dependent tolerance induction and efficiency of alloimmunization in sickle cell disease. Molecular Immunology 2009 47 1 64 70 2-s2.0-70350618088 10.1016/j.molimm.2008.12.027
29. von Muhlen C. A., Tan E. M., Autoantibodies in the diagnosis of systemic rheumatic diseases. Seminars in Arthritis and Rheumatism 1995 24 5 323 358 2-s2.0-0028922074
30. Vigorito E., Bell S., Hebeis B. J., Reynolds H., McAdam S., Emson P. C., McKenzie A., Turner M., Immunological function in mice lacking the rac-related GTPase RhoG. Molecular and Cellular Biology 2004 24 2 719 729 2-s2.0-0346095321 10.1128/MCB.24.2.719-729.2004 (Pubitemid 38057923)
31. Kawashima K., Fujii T., The lymphocytic cholinergic system and its biological function. Life Sciences 2003 72 18-19 2101 2109 2-s2.0-0037470612 10.1016/S0024-3205(03)00068-7 (Pubitemid 36298953)
32. Sanyal M., Fernandez R., Levy S., Enhanced B cell activation in the absence of CD81. International Immunology 2009 21 11 1225 1237 2-s2.0-71049117164 10.1093/intimm/dxp090
33. Cherukuri A., Carter R. H., Brooks S., Bornmann W., Finn R., Dowd C. S., Pierce S. K., B cell signaling is regulated by induced palmitoylation of CD81. Journal of Biological Chemistry 2004 279 30 31973 31982 2-s2.0-3843101584 10.1074/jbc.M404410200 (Pubitemid 39037872)
34. Tarrant J. M., Groom J., Metcalf D., Li R., Borobokas B., Wright M. D., Tarlinton D., Robb L., The absence of Tssc6, a member of the tetraspanin superfamily, does not affect lymphoid development but enhances in vitro T-cell proliferative responses. Molecular and Cellular Biology 2002 22 14 5006 5018 2-s2.0-0036291471 10.1128/MCB.22.14.5006-5018.2002 (Pubitemid 34700693)
35. Jongstra-Bilen J., Wielowieyski A., Misener V., Jongstra J., LSP1 regulates anti-IgM induced apoptosis in WEHI-231 cells and normal immature B-cells. Molecular Immunology 1999 36 6 349 359 2-s2.0-0032807863 10.1016/S0161-5890(99)00055-3 (Pubitemid 29331644)
36. Yamakami M., Yokosawa H., Tom1 (target of Myb 1) is a novel negative regulator of interleukin-1-and tumor necrosis factor-induced signaling pathways. Biological and Pharmaceutical Bulletin 2004 27 4 564 566 2-s2.0-15744361975 10.1248/bpb.27.564 (Pubitemid 41701846)
37. Karamatic Crew V., Poole J., Long S., Warke N., Colavecchia C., Burton N., Moulds M., Schlanser G., Wilson L., Noumsi G., Moulds J. M., Moulds J. J., Daniels G., Two MER2-negative individuals with the same novel CD151 mutation and evidence for clinical significance of anti-MER2. Transfusion 2008 48 9 1912 1916 2-s2.0-50849095438 10.1111/j.1537-2995.2008.01792.x
38. Zhang L., Pagano J. S., Structure and function of IRF-7. Journal of Interferon and Cytokine Research 2002 22 1 95 101 2-s2.0-0036179714 10.1089/107999002753452700 (Pubitemid 34161287)
39. Wald D., Qin J., Zhao Z., Qian Y., Naramura M., Tian L., Towne J., Sims J. E., Stark G. R., Li X., SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nature Immunology 2003 4 9 920 927 2-s2.0-0042733592 10.1038/ni968 (Pubitemid 37098664)
40. Lasalle-Williams M., Nuss R., Le T., Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME). Transfusion 2011 51 1732 1739
41. Sherry S. T., Ward M. H., Kholodov M., Baker J., Phan L., Smigielski E. M., Sirotkin K., DbSNP: the NCBI database of genetic variation. Nucleic Acids Research 2001 29 1 308 311 2-s2.0-0035173378 (Pubitemid 32054478)
42. Hodgkinson A., Eyre-Walker A., Human triallelic sites: evidence for a new mutational mechanism? Genetics 2010 184 1 233 241 2-s2.0-74249110768 10.1534/genetics.109.110510
43. Keclard L., Romana M., Lavocat E., Saint-Martin C., Berchel C., Merault G., Sickle cell disorder, beta-globin gene cluster haplotypes and alpha-thalassemia in neonates and adults from Guadeloupe. American Journal of Hematology 1997 55 24 27 (Pubitemid 27202399)
44. Belmont J. W., Hardenbol P., Willis T. D., Yu F., Yang H., Ch'Ang L. Y., Huang W., Liu B., Shen Y., Tam P. K. H., Tsui L. C., Waye M. M. Y., Wong J. T. F., Zeng C., Zhang Q., Chee M. S., Galver L. M., Kruglyak S., Murray S. S., Oliphant A. R., Montpetit A., Chagnon F., Ferretti V., Leboeuf M., Phillips M. S., Verner A., Duan S., Lind D. L., Miller R. D., Rice J., Saccone N. L., Taillon-Miller P., Xiao M., Sekine A., Sorimachi K., Tanaka Y., Tsunoda T., Yoshino E., Bentley D. R., Hunt S., Powell D., Zhang H., Matsuda I., Fukushima Y., Macer D. R., Suda E., Rotimi C., Adebamowo C. A., Aniagwu T., Marshall P. A., Matthew O., Nkwodimmah C., Royal C. D. M., Leppert M. F., Dixon M., Cunningham F., Kanani A., Thorisson G. A., Chen P. E., Cutler D. J., Kashuk C. S., Donnelly P., Marchini J., McVean G. A. T., Myers S. R., Cardon L. R., Morris A., Weir B. S., Mullikin J. C., Feolo M., Daly M. J., Qiu R., Kent A., Dunston G. M., Kato K., Niikawa N., Watkin J., Gibbs R. A., Sodergren E., Weinstock G. M., Wilson R. K., Fulton L. L., Rogers J., Birren B. W., Han H., Wang H., Godbout M., Wallenburg J. C., L'Archevêque P., Bellemare G., Todani K., Fujita T., Tanaka S., Holden A. L., Collins F. S., Brooks L. D., McEwen J. E., Guyer M. S., Jordan E., Peterson J. L., Spiegel J., Sung L. M., Zacharia L. F., Kennedy K., Dunn M. G., Seabrook R., Shillito M., Skene B., Stewart J. G., Valle D. L., Clayton E. W., Jorde L. B., Chakravarti A., Cho M. K., Duster T., Foster M. W., Jasperse M., Knoppers B. M., Kwok P. Y., Licinio J., Long J. C., Ossorio P., Wang V. O., Rotimi C. N., Spallone P., Terry S. F., Lander E. S., Lai E. H., Nickerson D. A., Abecasis G. R., Altshuler D., Boehnke M., Deloukas P., Douglas J. A., Gabriel S. B., Hudson R. R., Hudson T. J., Kruglyak L., Nakamura Y., Nussbaum R. L., Schaffner S. F., Sherry S. T., Stein L. D., Tanaka T., The international HapMap project. Nature 2003 426 6968 789 796 2-s2.0-79959503826 10.1038/nature02168 (Pubitemid 38056856)
45. Pagnier J., Mears J. G., Dunda Belkhodja O., Evidence for the multicentric origin of the sickle cell hemoglobin gene in Africa. Proceedings of the National Academy of Sciences of the United States of America 1984 81 6 1771 1773 2-s2.0-0344620583 (Pubitemid 14149545)
46. Elion J., Berg P. E., Lapoumeroulie C., Trabuchet G., Mittelman M., Krishnamoorthy R., Schechter A. N., Labie D., DNA sequence variation in a negative control region 5′ to the β -globin gene correlates with the phenotypic expression of the β (s) mutation. Blood 1992 79 3 787 792 2-s2.0-0026570768
47. Blajchman M. A., Immunomodulation and blood transfusion. American Journal of Therapeutics 2002 9 5 389 395 2-s2.0-0036727530
48. Vamvakas E. C., Blajchman M. A., Transfusion-related immunomodulation (TRIM): an update. Blood Reviews 2007 21 6 327 348 2-s2.0-34848892687 10.1016/j.blre.2007.07.003 (Pubitemid 47498679)
49. Zimring J. C., Hendrickson J. E., The role of inflammation in alloimmunization to antigens on transfused red blood cells. Current Opinion in Hematology 2008 15 6 631 635 2-s2.0-55149109425 10.1097/MOH.0b013e328313695e
50. Chies J. A. B., Nardi N. B., Sickle cell disease: a chronic inflammatory condition. Medical Hypotheses 2001 57 1 46 50 2-s2.0-0035758124 10.1054/mehy.2000.1310
51. Hendrickson J. E., Desmarets M., Deshpande S. S., Chadwick T. E., Hillyer C. D., Roback J. D., Zimring J. C., Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion 2006 46 9 1526 1536 2-s2.0-33748331170 10.1111/j.1537-2995.2006. 00946.x (Pubitemid 44326328)
52. Jison M. L., Munson P. J., Barb J. J., Suffredini A. F., Talwar S., Logun C., Raghavachari N., Beigel J. H., Shelhamer J. H., Danner R. L., Gladwin M. T., Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease. Blood 2004 104 1 270 280 2-s2.0-3042799335 10.1182/blood-2003-08-2760 (Pubitemid 38879868)
53. Hibbert J. M., Hsu L. L., Bhathena S. J., Irune I., Sarfo B., Creary M. S., Gee B. E., Mohamed A. I., Buchanan I. D., Al-Mahmoud A., Stiles J. K., Proinflammatory cytokines and the hypermetabolism of children with sickle cell disease. Experimental Biology and Medicine 2005 230 1 68 74 2-s2.0-19944367893 (Pubitemid 40041074)
54. Croizat H., Circulating cytokines in sickle cell patients during steady state. British Journal of Haematology 1994 87 3 592 597 2-s2.0-0028247316 (Pubitemid 24230028)
55. Taylor S. C., Shacks S. J., Qu Z., Wiley P., Type 2 cytokine serum levels in healthy sickle cell disease patients. Journal of the National Medical Association 1997 89 11 753 757 2-s2.0-0031263208 (Pubitemid 127455040)
56. Bourantas K. L., Dalekos G. N., Makis A., Chaidos A., Tsiara S., Mavridis A., Acute phase proteins and interleukins in steady state sickle cell disease. European Journal of Haematology 1998 61 1 49 54 2-s2.0-0031844580 (Pubitemid 28326403)
57. Raghupathy R., Haider M. Z., Azizieh F., Abdelsalam R., D'Souza T. M., Adekile A. D., Th1 and Th2 cytokine profiles in sickle cell disease. Acta Haematologica 2000 103 4 197 202 2-s2.0-0033798446
58. Becker K. G., Simon R. M., Bailey-Wilson J. E., Freidlin B., Biddison W. E., Mcfarland H. F., Trent J. M., Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proceedings of the National Academy of Sciences of the United States of America 1998 95 17 9979 9984 2-s2.0-0032544004 10.1073/pnas.95.17.9979 (Pubitemid 28415280)
59. Levy S., Shoham T., The tetraspanin web modulates immune-signalling complexes. Nature Reviews Immunology 2005 5 2 136 148 2-s2.0-13444259476 10.1038/nri1548 (Pubitemid 40208903)
60. Levy S., Todd S. C., Maecker H. T., CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annual Review of Immunology 1998 16 89 109 2-s2.0-0031895778 10.1146/annurev.immunol.16.1.89 (Pubitemid 28183360)
61. Morelli A. E., Larregina A. T., Shufesky W. J., Sullivan M. L. G., Stolz D. B., Papworth G. D., Zahorchak A. F., Logar A. J., Wang Z., Watkins S. C., Falo L. D., Thomson A. W., Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood 2004 104 10 3257 3266 2-s2.0-8644286802 10.1182/blood-2004-03-0824 (Pubitemid 39507144)
62. Mantegazza A. R., Barrio M. M., Moutel S., Bover L., Weck M., Brossart P., Teillaud J. L., Mordoh J., CD63 tetraspanin slows down cell migration and translocates to the endosomal-lysosomal-MIICs route after extracellular stimuli in human immature dendritic cells. Blood 2004 104 4 1183 1190 2-s2.0-3843126411 10.1182/blood-2004-01-0104 (Pubitemid 39038041)
63. Wyszynski D. F., Baldwin C. T., Cleves M. A., Amirault Y., Nolan V. G., Farrell J. J., Bisbee A., Kutlar A., Farrer L. A., Steinberg M. H., Polymorphisms near a chromosome 6q QTL area are associated with modulation of fetal hemoglobin levels in sickle cell anemia. Cellular and Molecular Biology 2004 50 1 23 33 2-s2.0-5144234546
64. Kumkhaek C., Taylor J. G., Zhu J., Hoppe C., Kato G. J., Rodgers G. P., Fetal haemoglobin response to hydroxycarbamide treatment and sar1a promoter polymorphisms in sickle cell anaemia. British Journal of Haematology 2008 141 2 254 259 2-s2.0-40949133859 10.1111/j.1365-2141.2008.07045.x (Pubitemid 351406217)
65. Bae H. T., Baldwin C. T., Sebastiani P., Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans. Blood 2012 120 1961 1962
66. Sankaran V. G., Xu J., Ragoczy T., Ippolito G. C., Walkley C. R., Maika S. D., Fujiwara Y., Ito M., Groudine M., Bender M. A., Tucker P. W., Orkin S. H., Developmental and species-divergent globin switching are driven by BCL11A. Nature 2009 460 7259 1093 1097 2-s2.0-69349092063 10.1038/nature08243
67. Galarneau G., Palmer C. D., Sankaran V. G., Orkin S. H., Hirschhorn J. N., Lettre G., Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation. Nature Genetics 2010 42 12 1049 1051 2-s2.0-78649469071 10.1038/ng.707
68. Machado R. D., Pauciulo M. W., Thomson J. R., Lane K. B., Morgan N. V., Wheeler L., Phillips J. A., Newman J., Williams D., Galiè N., Manes A., McNeil K., Yacoub M., Mikhail G., Rogers P., Corris P., Humbert M., Donnai D., Martensson G., Tranebjaerg L., Loyd J. E., Trembath R. C., Nichols W. C., BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. American Journal of Human Genetics 2001 68 1 92 102 2-s2.0-0035163071 10.1086/316947 (Pubitemid 32048364)
69. Nichols W. C., Koller D. L., Slovis B., Foroud T., Terry V. H., Arnold N. D., Siemieniak D. R., Wheeler L., Phillips J. A., Newman J. H., Conneally P. M., Ginsburg D., Loyd J. E., Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31-32. Nature Genetics 1997 15 3 277 280 2-s2.0-0031019091 10.1038/ng0397-277 (Pubitemid 27098722)
70. Ashley-Koch A. E., Elliott L., Kail M. E., De Castro L. M., Jonassaint J., Jackson T. L., Price J., Ataga K. I., Levesque M. C., Weinberg J. B., Orringer E. P., Collins A., Vance J. M., Telen M. J., Identification of genetic polymorphisms associated with risk for pulmonary hypertension in sickle cell disease. Blood 2008 111 12 5721 5726 2-s2.0-47049113837 10.1182/blood-2007-02- 074849
71. Sharan K., Surrey S., Ballas S., Borowski M., Devoto M., Wang K. F., Sandler E., Keller M., Association of T-786C eNOS gene polymorphism with increased susceptibility to acute chest syndrome in females with sickle cell disease. British Journal of Haematology 2004 124 2 240 243 2-s2.0-1642458091 10.1046/j.1365-2141.2003.04762.x (Pubitemid 38122198)
72. Zennadi R., Hines P. C., De Castro L. M., Cartron J. P., Parise L. V., Telen M. J., Epinephrine acts through erythroid signaling pathways to activate sickle cell adhesion to endothelium via LW- α v β 3 interactions. Blood 2004 104 12 3774 3781 2-s2.0-4544273781 10.1182/blood-2004-01-0042 (Pubitemid 39564457)
73. Tamouza R., Neonato M. G., Busson M., Marzais F., Girot R., Labie D., Elion J., Charron D., Infectious complications in sickle cell disease are influenced by HLA class II alleles. Human Immunology 2002 63 3 194 199 2-s2.0-0036129580 10.1016/S0198-8859(01)00378-0 (Pubitemid 34246052)
74. Hoppe C., Klitz W., Cheng S., Apple R., Steiner L., Robles L., Girard T., Vichinsky E., Styles L., Gene interactions and stroke risk in children with sickle cell anemia. Blood 2004 103 6 2391 2396 2-s2.0-1542283710 10.1182/blood-2003-09-3015 (Pubitemid 38326263)
75. Alarif L., Castro O., Ofosu M., HLA-B35 is associated with red cell alloimmunization in sickle cells disease. Clinical Immunology and Immunopathology 1986 38 2 178 183 2-s2.0-0022638805 (Pubitemid 16232201)